Our cancer test “N-NOSE” will be rolled out in 47 prefectures nationwide this summer.
We have established “N-NOSE” as an entrance test for cancer screening, which allows you to comprehensively check the risk of cancer just by staying at home. We are aiming to lead to early detection and treatment of cancer in people with cancer.
HIROTSU BIO SCIENCE Corporation is proud to announce the opening of a store on Tmall Global, the largest cross-border EC platform in China opera . . .2023.08.22
Hirotsu Bio Science Inc. (Headquarters: Chiyoda-ku, Tokyo, Representative Director: Takaaki Hirotsu) has signed a memorandum of understanding wi . . .2023.06.13
On Thursday, March 16, "DAVOS 2023 DEBRIEFING" was held by the Consulate of Switzerland in Osaka.Our CMO/CGO, Shunsuke Mizushima, was invited as . . .2023.03.20